Aberrant RNA translation in fragile X syndrome: From FMRP mechanisms to emerging therapeutic strategies
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Research in the past decades has unfolded the multifaceted role of Fragile X mental retardation protein (FMRP) and how its absence contributes to the pathophysiology of Fragile X syndrome (FXS). Excess signaling through group 1 metabotropic glutamate receptors is commonly observed in mouse models of FXS, which in part is attributed to dysregulated translation and downstream signaling. Considering the wide spectrum of cellular and physiologic functions that loss of FMRP can affect in general, it may be advantageous to pursue disease mechanism based treatments that directly target translational components or signaling factors that regulate protein synthesis. Various FMRP targets upstream and downstream of the translational machinery are therefore being investigated to further our understanding of the molecular mechanism of RNA and protein synthesis dysregulation in FXS as well as test their potential role as therapeutic interventions to alleviate FXS associated symptoms. In this review, we will broadly discuss recent advancements made towards understanding the role of FMRP in translation regulation, new pre-clinical animal models with FMRP targets located at different levels of the translational and signal transduction pathways for therapeutic intervention as well as future use of stem cells to model FXS associated phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · cited 7×
“Therefore, many studies have focused on identifying common sequence motifs amongst confirmed FMRP target RNAs (Ascano et al., 2012; Darnell et al., 2001; Darnell et al., 2011; Suhl et al., 2014).”
BackgroundInfluentialThe mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 3×
“Among the several neuronal signaling pathways implicated in FXS, mGluR pathway is probably the most extensively studied, eventually leading to the mGluR theory which states that absence of FMRP results in exaggerated mGlu5- mediated protein synthesis, dysregulated signaling and aberrant synaptic plasticity (Bear et al…”
BackgroundResultAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 1×
“mGlu5 dependent LTD is enhanced in mice lacking FMRP (Huber et al., 2002), yet is protein synthesis independent in Fmr1 KO mice (Nosyreva and Huber, 2006).”
BackgroundBrown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109 · cited 2×
“Early studies identified the G-quadruplex structures as a reoccurring feature of FMRP targets through both FMRP-RNA co-immunoprecipitation (RIP-CHIP) (Brown et al., 2001) and oligonucleotidebased systematic evolution of ligands by exponential enrichment (SELEX) (Darnell et al.”
BackgroundBrennan, C. M., & Steitz*, J. A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000854 · Cited by 1,095 · cited 1×
“HuR typically binds adenine/guanine rich elements in mRNAs and promotes mRNA stabilization (Brennan and Steitz, 2001).”
BackgroundFragile X mental retardation protein targets G quartet mRNAs important for neuronal function
Darnell, J. C., Jensen, K. B., Jin, P., Brown, V., Warren, S. T., & Darnell, R. B. (2001) · Cell · doi:10.1016/s0092-8674(01)00566-9 · Cited by 952
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838 · cited 1×
“A comprehensive review on current drug development and recent clinical trials in FXS can be found in reviews published recently (Berry-Kravis et al., 2017; Hagerman et al., 2017).”
BackgroundRegulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and miR-132
Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C.-F., Seeburg, D. P., Batterton, M. N., Tada, T., Dolan, B. M., Sharp, P. A., & Sheng, M. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.005 · Cited by 735 · cited 1×
“As another example, FMRP cooperates with miR-125b to suppress translation of NR2A mRNA (Edbauer et al., 2010).”
FMRP targets distinct mRNA sequence elements to regulate protein expression
Ascano, M., Mukherjee, N., Bandaru, P., Miller, J. B., Nusbaum, J. D., Corcoran, D. L., Langlois, C., Munschauer, M., Dewell, S., Hafner, M., et al. (2012) · Nature · doi:10.1038/nature11737 · Cited by 701
Steward, O., & Levy, W. (1982) · The Journal of Neuroscience · doi:10.1523/jneurosci.02-03-00284.1982 · Cited by 676 · cited 2×
“The case for local translation in neurons was gaining traction following the identification of polyribosomes in dendrites and at spines (Steward and Levy, 1982) and the mounting evidence of local protein synthesis in neurons (Rao and Steward, 1991; Torre and Steward, 1992).”
BackgroundThe protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
Siomi, H., Siomi, M. C., Nussbaum, R. L., & Dreyfuss, G. (1993) · Cell · doi:10.1016/0092-8674(93)90420-u · Cited by 641
Dynamic visualization of local protein synthesis in hippocampal neurons
Aakalu, G., Smith, W. B., Nguyen, N., Jiang, C., & Schuman, E. M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00295-1 · Cited by 611
The Fragile X Syndrome Protein Represses Activity-Dependent Translation through CYFIP1, a New 4E-BP
Napoli, I., Mercaldo, V., Boyl, P. P., Eleuteri, B., Zalfa, F., De Rubeis, S., Di Marino, D., Mohr, E., Massimi, M., Falconi, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.031 · Cited by 609
Dysregulation of mTOR signaling in fragile X syndrome
Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., & Zukin, R. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3696-09.2010 · Cited by 557
PI3K signalling in inflammation
Hawkins, P. T., & Stephens, L. R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.006 · Cited by 541 · cited 1×
“It is important to note that targeting specific components of PI3K signaling pathway rather than global reduction is desirable as the overall signaling pathway remains intact which is essential for various other cellular functions (Hawkins and Stephens, 2015; Stark et al., 2015; Vyas and Vohora, 2017).”
BackgroundAnalysis of neocortex in three males with the Fragile X syndrome
Hinton, V. J., Brown, W. T., Wisniewski, K., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320410306 · Cited by 527 · cited 1×
“Following the findings of impaired dendritic spine morphology in brain tissue of patients with FXS (Hinton et al., 1991; Irwin et al., 2001; Rudelli et al., 1985), much research was focused on understanding spine phenotypes.”
BackgroundDictenberg, J. B., Swanger, S. A., Antar, L. N., Singer, R. H., & Bassell, G. J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.04.003 · Cited by 511
Self-citationFrom mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
Bagni, C., & Greenough, W. T. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1667 · Cited by 475 · cited 1×
“A hallmark phenotype has been the preponderance of long, thin and morphologically immature dendritic spines (Bagni and Greenough, 2005).”
BackgroundOstroff, L. E., Fiala, J. C., Allwardt, B., & Harris, K. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00785-7 · Cited by 461 · cited 1×
“Strong synaptic stimulation has been shown to determine the translocation of the polyribosomes from the base of the spine into the spine head (Ostroff et al., 2002), raising the possibility that some translation occurs in the spine head.”
BackgroundMuddashetty, R. S., Kelić, S., Gross, C., Xu, M., & Bassell, G. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0937-07.2007 · Cited by 421
Self-citationAntar, L. N., Afroz, R., Dictenberg, J. B., Carroll, R. C., & Bassell, G. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0099-04.2004 · Cited by 411
Self-citationOsterweil, E. K., Krueger, D. D., Reinhold, K., & Bear, M. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3888-10.2010 · Cited by 384 · cited 2×
“This hypothesis has now been supported and verified by several bodies of research (Osterweil et al., 2010; Qin et al., 2013).”
BackgroundResultMuddashetty, R. S., Nalavadi, V. C., Gross, C., Yao, X., Xing, L., Laur, O., Warren, S. T., & Bassell, G. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.006 · Cited by 364
Self-citationAdult fragile X syndrome: Clinico-neuropathologic findings
Rudelli, R. D., Brown, W. T., Wisniewski, K., Jenkins, E. C., Laure-Kamionowska, M., Connell, F., & Wisniewski, H. M. (1985) · Acta Neuropathologica · doi:10.1007/bf00687814 · Cited by 362 · cited 2×
“Following the findings of impaired dendritic spine morphology in brain tissue of patients with FXS (Hinton et al., 1991; Irwin et al., 2001; Rudelli et al., 1985), much research was focused on understanding spine phenotypes.”
BackgroundDrug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Berry-Kravis, E. M., Lindemann, L., Jønch, A. E., Apostol, G., Bear, M. F., Carpenter, R. L., Crawley, J. N., Curie, A., Des Portes, V., Hossain, F., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.221 · Cited by 336 · cited 1×
“A comprehensive review on current drug development and recent clinical trials in FXS can be found in reviews published recently (Berry-Kravis et al., 2017; Hagerman et al., 2017).”
BackgroundPhosphorylation influences the translation state of FMRP-associated polyribosomes
Ceman, S., O'Donnell, W. T., Reed, M., Patton, S., Pohl, J., & Warren, S. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg350 · Cited by 327 · cited 2×
“, 2011), phosphorylation can also regulate the downstream effects of FMRP-polyribosome interactions (Ceman et al., 2003).”
BackgroundDelayed Stabilization of Dendritic Spines in Fragile X Mice
Cruz-Martin, A., Crespo, M., & Portera-Cailliau, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0577-10.2010 · Cited by 321 · cited 1×
“time-lapse imaging in L2/3 cortex revealed a persistent increase in spine instability in Fmr1 KO mice, suggestive of developmental delay (Cruz-Martin et al., 2010; Suresh and Dunaevsky, 2017).”
BackgroundBhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A. C., Murphy, J. P., Pierre, P., & Klann, E. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.022 · Cited by 316 · cited 2×
“Several of the above-mentioned phenotypes, including increased protein synthesis, could be reduced to wildtype levels with both genetic reduction and pharmacological inhibition of S6K1, suggesting S6K1 as an attractive target in FXS treatment (Bhattacharya et al., 2012; Bhattacharya et al., 2016; Sawicka et al., 2016).”
BackgroundSchenck, A., Bardoni, B., Langmann, C., Harden, N., Mandel, J.-L., & Giangrande, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00354-4 · Cited by 316 · cited 1×
“FMRP interacts with a number of proteins among which are: its homologues FXR1 and FXR2 (Zhang et al., 1995), nucleolin (Ceman et al., 1999), NUFIP (Bardoni et al., 1999) and CYFP1/2 (Napoli et al., 2008; Schenck et al., 2003).”
BackgroundDarnell, J. C., Fraser, C. E., Mostovetsky, O., Stefani, G., Jones, T. A., Eddy, S. R., & Darnell, R. B. (2005) · Genes & Development · doi:10.1101/gad.1276805 · Cited by 287 · cited 1×
“Exploitation of the I304N FMRP mutation (as described previously) has demonstrated the essential role of the KH2 domain in FMRP-polyribosome association (Darnell et al., 2005; Feng et al., 1997).”
BackgroundDysregulation and restoration of translational homeostasis in fragile X syndrome
Richter, J. D., Bassell, G. J., & Klann, E. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4001 · Cited by 275 · cited 9×
“[PubMed: 26283917] Richter JD, Bassell GJ, Klann E, 2015 Dysregulation and restoration of translational homeostasis in fragile X syndrome.”
BackgroundInfluentialSelf-citationFragile X mental retardation protein is associated with translating polyribosomes in neuronal cells
Stefani, G., Fraser, C. E., Darnell, J. C., & Darnell, R. B. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2306-04.2004 · Cited by 274 · cited 1×
“FMRP has been well characterized to directly associate with polyribosomes (Corbin et al., 1997; Darnell et al., 2011; Stefani et al., 2004), suggesting another mode by which FMRP can directly regulate translation.”
BackgroundSiomi, M. C., Zhang, Y., Siomi, H., & Dreyfuss, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3825 · Cited by 271 · cited 1×
“FMRP is normally associated with the translational machinery (Corbin et al., 1997; Feng et al., 1997; Siomi et al., 1996; Tamanini et al., 1996).”
BackgroundRescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486
Dolan, B. M., Duron, S. G., Campbell, D. A., Vollrath, B., Rao, B. S. S., Ko, H.-Y., Lin, G. G., Govindarajan, A., Choi, S.-Y., & Tonegawa, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219383110 · Cited by 260 · cited 1×
“In fact, PAK or Rac1 activity when inhibited by small molecule inhibitors rescued altered glutamatergic signaling, impaired sensory processing and abnormal fear conditioning in FXS mice (Dolan et al., 2013; Martinez and Tejada-Simon, 2017; Pyronneau et al., 2017).”
BackgroundG-quadruplex RNA structure as a signal for neurite mRNA targeting
Subramanian, M., Rage, F., Tabet, R., Flatter, E., Mandel, J., & Moine, H. (2011) · The EMBO Reports · doi:10.1038/embor.2011.76 · Cited by 250 · cited 1×
“The function of RGG box binding to FMRP targets may therefore be important for mRNA localization (Stefanovic et al., 2015; Subramanian et al., 2011).”
BackgroundOsterweil, E. K., Chuang, S.-C., Chubykin, A. A., Sidorov, M., Bianchi, R., Wong, R. K. S., & Bear, M. F. (2013) · Neuron · doi:10.1016/j.neuron.2012.01.034 · Cited by 230
Narayanan, U., Nalavadi, V., Nakamoto, M., Pallas, D. C., Ceman, S., Bassell, G. J., & Warren, S. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2969-07.2007 · Cited by 228 · cited 1×
“Downstream of mGlu5 signaling, FMRP is dephosphorylated by PP2A, as a switch to de-repress translation (Muddashetty et al., 2011; Narayanan et al., 2007).”
BackgroundSelf-citationReinhard, S. M., Razak, K., & Ethell, I. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00280 · Cited by 219 · cited 1×
“Higher MMP-9 activity, which is in part attributed to increased eIF4E phosphorylation and enhanced mTORC1/ERK signaling, has been previously reported in Fmr1 KO mouse brains, suggesting that MMP-9 dysregulation may contribute to FXS-associated deficits (Gkogkas et al., 2014; Reinhard et al., 2015).”
BackgroundNarayanan, U., Nalavadi, V., Nakamoto, M., Thomas, G., Ceman, S., Bassell, G. J., & Warren, S. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800055200 · Cited by 216 · cited 3×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript serine 499 (Narayanan et al., 2008).”
BackgroundInfluentialSelf-citationThe FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits
Christie, S. B., Akins, M. R., Schwob, J. E., & Fallon, J. R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3937-08.2009 · Cited by 208
Pan, F., Aldridge, G. M., Greenough, W. T., & Gan, W.-B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012496107 · Cited by 208
Gkogkas, C. G., Khoutorsky, A., Cao, R., Jafarnejad, S. M., Prager-Khoutorsky, M., Giannakas, N., Kaminari, A., Fragkouli, A., Nader, K., Price, T. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.064 · Cited by 201 · cited 1×
“Higher MMP-9 activity, which is in part attributed to increased eIF4E phosphorylation and enhanced mTORC1/ERK signaling, has been previously reported in Fmr1 KO mouse brains, suggesting that MMP-9 dysregulation may contribute to FXS-associated deficits (Gkogkas et al., 2014; Reinhard et al., 2015).”
BackgroundCeman, S., Brown, V., & Warren, S. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.7925 · Cited by 181
Park, C.-Y., Halevy, T., Lee, D. R., Sung, J. J., Lee, J. S., Yanuka, O., Benvenisty, N., & Kim, D.-W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.084 · Cited by 178 · cited 1×
“To this end, they employed a CRISPR/Cas9-mediated strategy to correct the expanded CGG repeat and showed that this resulted in demethylation of FMR1 as well as restoration of FMR1 mRNA in iPSCs as well as neural progenitor cells and neurons (Park et al., 2015).”
MethodAstrocytes prevent abnormal neuronal development in the fragile X mouse.
Jacobs, S., & Doering, L. C. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5027-09.2010 · Cited by 170
iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth
Doers, M. E., Musser, M. T., Nichol, R., Berndt, E. R., Baker, M., Gomez, T. M., Zhang, S.-C., Abbeduto, L., & Bhattacharyya, A. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0030 · Cited by 165 · cited 1×
“In another study, FXS patient iPSC derived forebrain neurons were found to have fewer and shorter neurites, as well as defects in neurite initiation and extension (Doers et al., 2014).”
BackgroundSidhu, H., Dansie, L. E., Hickmott, P. W., Ethell, D. W., & Ethell, I. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1162-14.2014 · Cited by 155
Fmr1 and Nlgn3 knockout rats: Novel tools for investigating autism spectrum disorders.
Hamilton, S. M., Green, J. R., Veeraragavan, S., Yuva, L., McCoy, A., Wu, Y., Warren, J., Little, L., Ji, D., Cui, X., et al. (2014) · Behavioral Neuroscience · doi:10.1037/a0035988 · Cited by 144
Bardoni, B., Schenck, A., & Louis Mandel, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.13.2557 · Cited by 136
Nalavadi, V. C., Muddashetty, R. S., Gross, C., & Bassell, G. J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5057-11.2012 · Cited by 128
Self-citationPyronneau, A., He, Q., Hwang, J.-Y., Porch, M., Contractor, A., & Zukin, R. S. (2017) · Science Signaling · doi:10.1126/scisignal.aan0852 · Cited by 122 · cited 1×
“In fact, PAK or Rac1 activity when inhibited by small molecule inhibitors rescued altered glutamatergic signaling, impaired sensory processing and abnormal fear conditioning in FXS mice (Dolan et al., 2013; Martinez and Tejada-Simon, 2017; Pyronneau et al., 2017).”
BackgroundGross, C., Chang, C.-W., Kelly, S. M., Bhattacharya, A., McBride, S. M. J., Danielson, S. W., Jiang, M. Q., Chan, C. B., Ye, K., Gibson, J. R., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.060 · Cited by 117
Self-citationLovelace, J. W., Wen, T. H., Reinhard, S., Hsu, M. S., Sidhu, H., Ethell, I. M., Binder, D. K., & Razak, K. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.002 · Cited by 115
The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses.
Janusz, A., Miłek, J., Perycz, M., Pacini, L., Bagni, C., Kaczmarek, L., & Dziembowska, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2207-13.2013 · Cited by 112
Till, S. M., Asiminas, A., Jackson, A. D., Katsanevaki, D., Barnes, S. A., Osterweil, E. K., Bear, M. F., Chattarji, S., Wood, E. R., Wyllie, D. J. A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv299 · Cited by 109 · cited 1×
“While Fmr1 KO mice has been the most widely used model to understand pathophysiology in FXS, researchers have also expanded their investigation using Fmr1 KO rats for better comparison of phenotypes that results from FMRP deletion as well as bridge gaps between mouse and human findings (Hamilton et al., 2014; Tian et…”
BackgroundHigashimori, H., Schin, C. S., Chiang, M. S. R., Morel, L., Shoneye, T. A., Nelson, D. L., & Yang, Y. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1069-16.2016 · Cited by 105 · cited 2×
“, 2013) and their selective deletion contributes to fragile x syndrome phenotypes in Fmr1 KO mice (Higashimori et al., 2016).”
BackgroundKaufmann, M., Schuffenhauer, A., Fruh, I., Klein, J., Thiemeyer, A., Rigo, P., Gomez-Mancilla, B., Heidinger-Millot, V., Bouwmeester, T., Schopfer, U., et al. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115588287 · Cited by 87
Higashimori, H., Morel, L., Huth, J., Lindemann, L., Dulla, C., Taylor, A., Freeman, M., & Yang, Y. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt055 · Cited by 85
Sawicka, K., Pyronneau, A., Chao, M., Bennett, M. V. L., & Zukin, R. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610812113 · Cited by 84 · cited 1×
“Several of the above-mentioned phenotypes, including increased protein synthesis, could be reduced to wildtype levels with both genetic reduction and pharmacological inhibition of S6K1, suggesting S6K1 as an attractive target in FXS treatment (Bhattacharya et al., 2012; Bhattacharya et al., 2016; Sawicka et al., 2016).”
BackgroundCheng, C., Lau, S. K. M., & Doering, L. C. (2016) · Molecular Brain · doi:10.1186/s13041-016-0256-9 · Cited by 84
Loss of FMRP Impaired Hippocampal Long-Term Plasticity and Spatial Learning in Rats
Tian, Y., Yang, C., Shang, S., Cai, Y., Deng, X., Zhang, J., Shao, F., Zhu, D., Liu, Y., Chen, G., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00269 · Cited by 82 · cited 1×
“While Fmr1 KO mice has been the most widely used model to understand pathophysiology in FXS, researchers have also expanded their investigation using Fmr1 KO rats for better comparison of phenotypes that results from FMRP deletion as well as bridge gaps between mouse and human findings (Hamilton et al., 2014; Tian et…”
BackgroundSuhl, J. A., Chopra, P., Anderson, B. R., Bassell, G. J., & Warren, S. T. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu272 · Cited by 81 · cited 2×
“Therefore, many studies have focused on identifying common sequence motifs amongst confirmed FMRP target RNAs (Ascano et al., 2012; Darnell et al., 2001; Darnell et al., 2011; Suhl et al., 2014).”
BackgroundSelf-citationGross, C., Raj, N., Molinaro, G., Allen, A. G., Whyte, A. J., Gibson, J. R., Huber, K. M., Gourley, S. L., & Bassell, G. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.065 · Cited by 71 · cited 2×
“This dysregulation specifically impacts mammalian target of rapamycin, mTOR signaling pathways (Gross et al., 2015a; Sharma et al., 2010).”
BackgroundSelf-citationSnapShot: FMRP mRNA Targets and Diseases
Pasciuto, E., & Bagni, C. (2014) · Cell · doi:10.1016/j.cell.2014.08.035 · Cited by 65
Bhattacharya, A., Mamcarz, M., Mullins, C., Choudhury, A., Boyle, R. G., Smith, D. G., Walker, D. W., & Klann, E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.369 · Cited by 51 · cited 1×
“Several of the above-mentioned phenotypes, including increased protein synthesis, could be reduced to wildtype levels with both genetic reduction and pharmacological inhibition of S6K1, suggesting S6K1 as an attractive target in FXS treatment (Bhattacharya et al., 2012; Bhattacharya et al., 2016; Sawicka et al., 2016).”
BackgroundCortical neurogenesis in fragile X syndrome
Castrén, M. L. (2016) · Frontiers in Bioscience · doi:10.2741/s455 · Cited by 24
Pharmacological Rescue of Hippocampal Fear Learning Deficits in Fragile X Syndrome
Martinez, L. A., & Tejada-Simon, M. V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0819-5 · Cited by 14
Cited by
Oscillospira - a candidate for the next-generation probiotics
Yang, J., Li, Y., Wen, Z., Liu, W., Meng, L., & Huang, H. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1987783 · Cited by 471
Tsang, B., Arsenault, J., Vernon, R. M., Lin, H., Sonenberg, N., Wang, L.-Y., Bah, A., & Forman-Kay, J. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814385116 · Cited by 339
The m6A epitranscriptome: transcriptome plasticity in brain development and function
Livneh, I., Moshitch-Moshkovitz, S., Amariglio, N., Rechavi, G., & Dominissini, D. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0244-z · Cited by 330
A synaptic perspective of fragile X syndrome and autism spectrum Disorders.
Bagni, C., & Zukin, R. S. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.041 · Cited by 326
“After more than 18 years of studies addressing the properties of neurons lacking FMRP, excessive translation is posited to be a major contributor to the synaptic and cognitive deficits in Fragile X syndrome (Bagni et al., 2012; Banerjee et al., 2018; Darnell and Klann, 2013; Richter et al., 2015).”
BackgroundRNA transport and local translation in neurodevelopmental and neurodegenerative disease
Fernandopulle, M. S., Lippincott-Schwartz, J., & Ward, M. E. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00785-2 · Cited by 183
Metadata
- Authors
- Banerjee, A., Ifrim, M. F., Valdez, A. N., Raj, N., & Bassell, G. J.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 1693
- Issue
- Pt A
- Pages
- 24-36
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2797244528
- Cited by
- 104
- References
- 67
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.